01 Sodium Valproate (1)
02 VALPROATE SODIUM (1)
01 ABBVIE (1)
02 Neogen N.V. (1)
01 INJECTABLE;INJECTION (1)
02 SOLUTION FOR INFUSION (1)
01 100MG/ML (1)
02 EQ 100MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
01 Canada (1)
02 USA (1)
19
AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is VALPROATE SODIUM, with a corresponding application number 20593 and regulatory information .
proudly manufactured in the
approval since 1996-12-30
AbbVie Inc's DEPACON INJECTABLE;INJECTION, medication with EQ 100MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of VALPROATE SODIUM.
18
Neogen N.V., based in Belgium, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is Sodium Valproate, with a corresponding application number 20593 and regulatory information .
proudly manufactured in the
Neogen N.V.'s SOLUTION FOR INFUSION , medication with 100MG/ML of Sodium Valproate.